MIAMI, FL. MARCH 27, 2018 — ArisGlobal, LLC, a global leader in providing cloud-based software solutions for the life sciences, will present at the World Drug Safety Congress Americas 2018 conference to be held in Philadelphia, PA from April 10-11, 2018, on the topic “Automation is transforming pharmacovigilance. Is your organization ready?”
Presented by Dr. Vivek Ahuja, Vice President, Global Pharmacovigilance, the presentation, scheduled for April 10, 2:30-2:50 p.m., is part of the conference’s Next Gen Tech Track. Dr. Ahuja will discuss whether artificial intelligence (AI) is more hype than reality, and how an organization can determine if it has the discipline to transform itself, how to find the right opportunities to explore, and then share the steps involved in implementing an AI strategy for pharmacovigilance.
“From being a mere exploratory experiment to giving an exhilarating experience, cognitive computing in pharmacovigilance is now fast evolving. Fairly soon, it will disrupt the way how drug safety departments will fulfill their compliance obligations. Early adopters will establish themselves as change leaders of the world of drug safety. My presentation will provide insight into how Marketing Authorization holders, CROs and even regulatory authorities can benefit from the technology advancements that AI can offer.”
ArisGlobal is an exhibitor and Gold Sponsor of World Drug Safety Congress and will be showcasing LifeSphere® Safety, its cognitive computing pharmacovigilance platform, in Booth #18. Attendees are invited to meet with ArisGlobal staff to learn about its innovative and leading pharmacovigilance and safety platform.
Download ArisGlobal’s 2024 Industry Report 
